Ventavis, Lösung für einen Vernebler

7680562130020 CH-56213 Lösung

Associated product:

VENTAVIS sol inhal 20 mcg/2ml 2 ml amp 30 pce
Ventavis, Lösung für einen Vernebler
Ventavis, Lösung für einen Vernebler
Ventavis, Lösung für einen Vernebler
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Ampulle(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/01/2021
Patient information leaflet
Français
22/01/2021
Patient information leaflet
Italien
22/01/2021
Summary of Product Characteristics
Allemand
22/01/2021
Summary of Product Characteristics
Français
22/01/2021
Summary of Product Characteristics
Italien
22/01/2021

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
0.75 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 890.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2008

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
56213
Drug name
Ventavis, Lösung für einen Vernebler
Galenic form
LSVE
ATC Code
B01AC11
Authorization status
Z
Dispensing category
B
First authorization
22/11/2005
Authorization expiration date
31/12/9999
IT Number
02.07.1.
Domain
Human medicine
Field of application
Primäre pulmonale Hypertonie

Package details

Description (FR)
VENTAVIS sol inhal 20 mcg/2ml 2 ml amp 30 pce
Description (DE)
VENTAVIS Inhal Lös 20 mcg/2ml 2 ml Amp 30 Stk
Market launch
22/11/2005
Narcotic (BTM)
No

Other package sizes (3)

None
None None
GTIN: None
Not in V1
VENTAVIS sol inhal 20 mcg/2ml 2 ml amp 300 pce
None None
GTIN: 7680562130068
Not in V1
VENTAVIS sol inhal 20 mcg/2ml 2 ml amp 10 x 30 pce
None None
GTIN: 7680562130082
Not in V1